BAX Q1 Deep Dive: Turnaround Progress Amid Margin Pressures and Product LaunchesHealthcare company Baxter International (
NYSE:BAX) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 2.9% year on year to...
Baxter’s (NYSE:BAX) Q1 CY2026: Strong Sales, Stock SoarsHealthcare company Baxter International (
NYSE:BAX) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 2.9% year on year to $2.7...
Baxter Reports First-Quarter 2026 Results
Baxter International Inc. (
NYSE: BAX), a global medtech leader, today reported results for the first quarter of 2026.
What To Expect From Baxter’s (BAX) Q1 EarningsHealthcare company Baxter International (
NYSE:BAX) will be announcing earnings results this Thursday before market hours. Here’s what to look for. Baxter bea...
1 Cash-Producing Stock with Solid Fundamentals and 2 We Turn DownA company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To KnowWhat Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener...
Avanos Medical to be Acquired by American Industrial Partners for $1.27 Billion; Stock Surges 69%The medical technology landscape witnessed a seismic shift on Tuesday as Avanos Medical (
NYSE: AVNS) announced it has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP) in an all-cash transaction valued at approximately $1.27 billion. The deal marks a significant turning point
Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026
Baxter International Inc. (
NYSE:BAX), a global medtech leader, is highlighting recent additions to its Global Surgical Solutions and Patient Support Systems portfolios, as well as its broad Advanced Surgery portfolio of hemostatic and sealing agents, at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo, taking place April 11-14, 2026 in New Orleans. New offerings include the AAT XR spine surgical table and the Dynamo Series smart stretcher, both on display at Baxter booth #1319.
The Teleflex Pivot: Inside the $1 Billion Share Buyback and Strategic BreakupDisclaimer: This content is intended for informational purposes only and is not financial advice. Today’s date is April 9, 2026. Introduction In the high-stakes arena of medical technology, few stories are as dramatic as the current transformation of Teleflex Incorporated (
NYSE: TFX). Once a darling of the "growth-at-any-cost" era, the Wayne, Pennsylvania-based company found itself [...]
Baxter to Host First-Quarter 2026 Financial Results Conference Call for Investors
Baxter International Inc. (
NYSE:BAX), a leading global medtech company, will host a conference call to discuss its first-quarter 2026 financial results on Thursday, April 30, 2026 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I946023356 to pre-register for the call and receive the call information.
2 Oversold Stocks Set for a Comeback and 1 We Brush OffThe past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet...
The “New BD”: A Deep-Dive Research Report on Becton, Dickinson and Company (BDX) in 2026As of April 3, 2026, the medical technology landscape is undergoing a radical transformation, and few companies embody this evolution more than Becton, Dickinson and Company (
NYSE: BDX). Known colloquially as BD, the firm has spent the last two years shedding its skin, moving from a broad-based healthcare conglomerate to a high-growth, high-margin "pure-play" medical [...]
The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)As of April 1, 2026, Becton, Dickinson and Company (
NYSE: BDX), commonly known as BD, finds itself at a historic crossroads. For decades, BD was viewed as a diversified healthcare conglomerate—a "steady Eddie" of the MedTech world that provided everything from basic syringes to complex diagnostic laboratory equipment. However, the recent completion of the Biosciences [...]
Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings
Baxter International Inc. (
NYSE:BAX), an innovative leader in infusion therapies and platforms, today debuted the IV Verify Line Labeling System, an automated solution, at the 2026 American Organization for Nursing Leadership Conference. The IV Verify system is designed to streamline nursing workflows, save clinician time and support safer medication administration at the bedside. Baxter’s launch of the product is the result of a strategic and exclusive distribution agreement with Vigilant Software, a leader in medication management safe practices.
3 Reasons to Avoid BAX and 1 Stock to Buy InsteadWhat a brutal six months it’s been for Baxter. The stock has dropped 24.9% and now trades at $16.81, rattling many shareholders. This was partly driven by it...
Baxter to Host Annual Meeting of Stockholders in Virtual Format
Baxter International Inc. (
NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2026 Annual Meeting) in a virtual format on Tuesday, May 5, 2026 at 9 a.m., Central Time, as disclosed in Baxter’s proxy statement for the 2026 Annual Meeting. Online access to the 2026 Annual Meeting will begin at 8:45 a.m., Central Time. Stockholders will not be able to attend the 2026 Annual Meeting in person. The virtual format provides a safe, convenient and cost-effective experience to all stockholders and employees, regardless of location.
1 Unprofitable Stock with Impressive Fundamentals and 2 That UnderwhelmUnprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Baxter Announces CFO Transition
Baxter International Inc. (
NYSE:BAX), a global medtech leader, today announced the departure of executive vice president and chief financial officer (CFO) Joel Grade. Mr. Grade is leaving the company to prioritize family matters but will continue in an advisory capacity until April 30, 2026.
